Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The price of ARS Pharmaceuticals Inc (NASDAQ: SPRY) closed at $14.22 in the last session, down -0.77% from day before closing price of $14.33. In other words, the price has decreased by -$0.77 from its previous closing price. On the day, 1.45 million shares were traded.
Ratios:
We take a closer look at SPRY’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 10.74 and its Current Ratio is at 11.00. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Scotiabank on March 07, 2025, initiated with a Sector Outperform rating and assigned the stock a target price of $30.
On February 10, 2025, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $40.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 20 ’25 when Scott Kathleen D. bought 50,000 shares for $14.10 per share.
Fitzpatrick Alexander A bought 102,969 shares of SPRY for $1,443,894 on May 20 ’25. On May 20 ’25, another insider, SAUNDERS BRENT L, who serves as the Director of the company, bought 120,000 shares for $14.25 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 14.38 while its Price-to-Book (P/B) ratio in mrq is 6.09.
Stock Price History:
Over the past 52 weeks, SPRY has reached a high of $18.51, while it has fallen to a 52-week low of $7.55. The 50-Day Moving Average of the stock is 6.22%, while the 200-Day Moving Average is calculated to be 8.34%.
Shares Statistics:
A total of 98.13M shares are outstanding, with a floating share count of 54.77M. Insiders hold about 44.23% of the company’s shares, while institutions hold 53.45% stake in the company.
